{"id":56972,"date":"2024-02-27T17:16:42","date_gmt":"2024-02-27T17:16:42","guid":{"rendered":"https:\/\/medsname.com\/ezedoc\/"},"modified":"2026-08-28T11:51:18","modified_gmt":"2026-08-28T11:51:18","slug":"ezedoc","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/ezedoc\/","title":{"rendered":"Lipikard"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Ezedoc?<\/h3>\n<p style=\"margin: 0;\"><strong>Lipikard<\/strong> obsahuje <strong>ezetimib<\/strong> (10 mg), <strong>inhibitor absorpce cholesterolu<\/strong> kter\u00fd blokuje transport\u00e9r NPC1L1 v tenk\u00e9m st\u0159ev\u011b. Je to <strong>go-to add-on therapy when a statin alone doesn\u2019t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17\u201322%. Added to a statin, it produces an additional ~20\u201325% LDL reduction, totaling a 55\u201360% fall \u2014 equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The <strong>IMPROVE-IT<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10\u00a0mg once daily, any time, with or without food. Generally very well-tolerated \u2014 mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a expedujeme je celosv\u011btov\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2014 \u017e\u00e1dn\u00e9 n\u00e1zvy l\u00e9k\u016f na vn\u011bj\u0161\u00ed stran\u011b z\u00e1silky. Platby kartou jsou zpracov\u00e1v\u00e1ny regulovan\u00fdm procesorem (v\u00fdpisy z \u00fa\u010dtu obsahuj\u00ed regulovan\u00e9ho zpracovatele plateb \u2014 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je kryta na\u0161\u00ed politikou z\u00e1ruky dod\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Ezedoc?<\/h2>\n<p>Ezedoc je peror\u00e1ln\u00ed hypolipidemikum obsahuj\u00edc\u00ed <strong>ezetimib<\/strong> (10 mg), vyr\u00e1b\u011bn\u00e9 v\u00fdrobcem certifikovan\u00fdm WHO-GMP. Dod\u00e1v\u00e1 se v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. Ezetimib je prvn\u00ed a jedin\u00fd l\u00e9k ze t\u0159\u00eddy <strong>inhibitor absorpce cholesterolu<\/strong> . Origin\u00e1ln\u00ed zna\u010dka: <strong>Zetia \/ Ezetrol<\/strong> (Merck, 2002).<\/p>\n<p>Ezetimibe is a mainstay of second-line lipid management \u2014 the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n<h2 class=\"wp-block-heading\">K \u010demu se Ezedoc pou\u017e\u00edv\u00e1?<\/h2>\n<ul>\n<li><strong>Prim\u00e1rn\u00ed hypercholesterol\u00e9mie<\/strong> \u2014 as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose<\/li>\n<li><strong>Nesn\u00e1\u0161enlivost statin\u016f<\/strong> \u2014 as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems<\/li>\n<li><strong>Famil\u00e1rn\u00ed hypercholesterolemie<\/strong> (heterozygous and homozygous) \u2014 in combination with statin<\/li>\n<li><strong>Sekund\u00e1rn\u00ed prevence po akutn\u00edm koron\u00e1rn\u00edm syndromu<\/strong> \u2014 add to statin to further reduce CV events (IMPROVE-IT trial)<\/li>\n<li><strong>Sitosterol\u00e9mie<\/strong> \u2014 a rare genetic condition where ezetimibe is disease-modifying<\/li>\n<\/ul>\n<p>Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30\u201360%); it is most powerful as an add-on.<\/p>\n<h2 class=\"wp-block-heading\">Jak funguje Ezedoc?<\/h2>\n<p>Ezetimib selektivn\u011b inhibuje <strong>transport\u00e9r Niemann-Pick C1-Like 1 (NPC1L1)<\/strong> na enterocytech v proxim\u00e1ln\u00edm tenk\u00e9m st\u0159ev\u011b. NPC1L1 je zodpov\u011bdn\u00fd za vst\u0159eb\u00e1v\u00e1n\u00ed cholesterolu z potravy a \u017elu\u010di ze st\u0159evn\u00edho lumen do enterocytu.<\/p>\n<p>P\u0159i blok\u00e1d\u011b NPC1L1:<\/p>\n<ul>\n<li><strong>St\u0159evn\u00ed absorpce cholesterolu kles\u00e1 o ~54%<\/strong><\/li>\n<li><strong>Jatern\u00ed z\u00e1soby cholesterolu se sni\u017euj\u00ed<\/strong> proto\u017ee do jater se dost\u00e1v\u00e1 m\u00e9n\u011b cholesterolu<\/li>\n<li><strong>LDL receptory jsou zv\u00fd\u0161eny<\/strong> on hepatocytes \u2014 the liver pulls more LDL out of the blood<\/li>\n<li><strong>Plasma LDL-C falls by 17\u201322%<\/strong> jako monoterapie; a\u017e o 25 % v\u00edce p\u0159i kombinaci se statinem<\/li>\n<li>Aktivita HMG-CoA redukt\u00e1zy (c\u00edl statin\u016f) z\u016fst\u00e1v\u00e1 nezm\u011bn\u011bna<\/li>\n<\/ul>\n<p>Proto\u017ee ezetimib a statiny p\u016fsob\u00ed na <strong>komplement\u00e1rn\u00ed dr\u00e1hy<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other\u2019s side-effect profile.<\/p>\n<p>\u00dadaje o v\u00fdsledc\u00edch: studie <strong>IMPROVE-IT<\/strong> (2015) prok\u00e1zala, \u017ee p\u0159id\u00e1n\u00ed ezetimibu k simvastatinu u pacient\u016f po ACS sn\u00ed\u017eilo kombinovan\u00fd kardiovaskul\u00e1rn\u00ed endpoint o 6,4 % (NNT 50 za 7 let), co\u017e potvrdilo, \u017ee sn\u00ed\u017een\u00ed LDL se prom\u00edt\u00e1 do skute\u010dn\u00e9ho sn\u00ed\u017een\u00ed ud\u00e1lost\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n<p><strong>Standardn\u00ed d\u00e1vka:<\/strong> 10\u00a0mg once daily at any time of day, with or without food.<\/p>\n<ul>\n<li>U\u017e\u00edvejte v pravidelnou dobu pro lep\u0161\u00ed adherenci.<\/li>\n<li>Can be taken at the same time as a statin or spaced out \u2014 no timing interaction.<\/li>\n<li>Miss a dose \u2014 take it as soon as you remember unless close to the next; do not double up.<\/li>\n<li>Nen\u00ed t\u0159eba upravovat d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00ed insuficienci nebo m\u00edrn\u00e9m a\u017e st\u0159edn\u00edm po\u0161kozen\u00ed jater.<\/li>\n<li>Monitor lipid panel and ALT at baseline and 6\u20138 weeks after starting. Check CK only if symptoms.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p>Ezetimib je jedn\u00edm z nejl\u00e9pe sn\u00e1\u0161en\u00fdch l\u00e9k\u016f na sn\u00ed\u017een\u00ed lipid\u016f. Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky jsou v studi\u00edch bl\u00edzk\u00e9 m\u00ed\u0159e placeba.<\/p>\n<p><strong>\u010cast\u00e9 (&lt; 5 %):<\/strong><\/p>\n<ul>\n<li>M\u00edrn\u00fd pr\u016fjem, plynatost<\/li>\n<li>Infekce horn\u00edch cest d\u00fdchac\u00edch, z\u00e1n\u011bt vedlej\u0161\u00edch nosn\u00edch dutin<\/li>\n<li>\u00danava<\/li>\n<li>Artralgie<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9:<\/strong><\/p>\n<ul>\n<li>Transaminase elevation \u2014 usually small; more common when combined with a statin<\/li>\n<li>Muscle pain, myalgia, myopathy \u2014 rare; primarily when combined with statin<\/li>\n<li>P\u0159ecitliv\u011blost, angioed\u00e9m, vyr\u00e1\u017eka<\/li>\n<li>Pancreatitis \u2014 very rare<\/li>\n<li>Cholelithiasis \u2014 very rare<\/li>\n<li>Thrombocytopenia \u2014 very rare<\/li>\n<li>Rhabdomyolysis \u2014 exceedingly rare, almost always in combination with a statin<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Cyklosporin<\/strong> \u2014 significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.<\/li>\n<li><strong>Sekvestranty \u017elu\u010dov\u00fdch kyselin<\/strong> (cholestyramine, colestipol) \u2014 reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.<\/li>\n<li><strong>Warfarin<\/strong> \u2014 occasional INR change reported; monitor when starting.<\/li>\n<li><strong>Statiny<\/strong> \u2014 no adverse PK interaction; this combination is the therapeutic mainstay.<\/li>\n<li><strong>Fibr\u00e1ty<\/strong> \u2014 fenofibrate\/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kdo by nem\u011bl u\u017e\u00edvat Ezedoc?<\/h2>\n<ul>\n<li>St\u0159edn\u011b t\u011b\u017ek\u00e9 a\u017e t\u011b\u017ek\u00e9 po\u0161kozen\u00ed jater (v kombinaci se statinem)<\/li>\n<li>Active liver disease or persistent transaminase elevation &gt; 3\u00d7 ULN<\/li>\n<li>T\u011bhotenstv\u00ed (v kombinaci se statinem)<\/li>\n<li>Kojen\u00ed<\/li>\n<li>D\u011bti &lt; 10 let (nedostate\u010dn\u00e9 \u00fadaje)<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na ezetimib<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Store Ezedoc below 25\u00b0C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Ezedoc m\u00edsto statinu?<\/h3>\n<p>Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% \u2014 much less than a statin (30\u201360%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n<h3 class=\"wp-block-heading\">Jak se Ezedoc srovn\u00e1v\u00e1 se zdvojn\u00e1soben\u00edm d\u00e1vky statinu?<\/h3>\n<p>Doubling a statin dose typically adds ~6% LDL reduction (the statin \u201crule of 6\u201d). Adding ezetimibe adds ~20\u201325% LDL reduction. <strong>Adding ezetimibe is 3\u20134\u00d7 more effective<\/strong> ne\u017e zdvojn\u00e1soben\u00ed d\u00e1vky statinu, a to bez zv\u00fd\u0161en\u00ed svalov\u00fdch p\u0159\u00edznak\u016f souvisej\u00edc\u00edch s d\u00e1vkou. Proto modern\u00ed doporu\u010den\u00ed up\u0159ednost\u0148uj\u00ed kombinaci statinu a ezetimibu p\u0159ed zv\u00fd\u0161en\u00edm d\u00e1vky statinu na maximum.<\/p>\n<h3 class=\"wp-block-heading\">Sni\u017euje Ezedoc riziko infarktu a mrtvice?<\/h3>\n<p>Yes \u2014 the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n<h3 class=\"wp-block-heading\">Kdy bych m\u011bl u\u017e\u00edvat Ezedoc?<\/h3>\n<p>Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent \u2014 pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsobuje Ezedoc bolesti sval\u016f jako statiny?<\/h3>\n<p>Z\u0159\u00eddka. Monoterapie ezetimibem vykazuje vedlej\u0161\u00ed \u00fa\u010dinky na \u00farovni placeba. V kombinaci se statinem v\u00fdznamn\u011b nezvy\u0161uje statinem vyvolan\u00e9 svalov\u00e9 p\u0159\u00edznaky ve srovn\u00e1n\u00ed se samotn\u00fdm statinem.<\/p>\n<h3 class=\"wp-block-heading\">Kde lze koupit Ezedoc online?<\/h3>\n<p>Ezedoc (10 mg) si m\u016f\u017eete objednat na MedsBase v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b s diskr\u00e9tn\u00edm balen\u00edm a z\u00e1sobami od certifikovan\u00e9ho v\u00fdrobce WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed l\u00e9ky na cholesterol<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/pivasta\/\">Pivasta \u2014 Pitavastatin (interaction-clean)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lipicard\/\">Lipicard \u2014 Fenofibrate (for triglycerides)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-cholesterol-treatments\/\"><strong>Prohl\u00e9dn\u011bte si v\u0161echny l\u00e9ky na vysok\u00fd cholesterol<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou pomoc kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Nevysv\u011btliteln\u00e9 bolesti sval\u016f, ze\u017eloutnut\u00ed k\u016f\u017ee nebo o\u010d\u00ed \u010di siln\u00e9 bolesti b\u0159icha vy\u017eaduj\u00ed okam\u017eit\u00e9 l\u00e9ka\u0159sk\u00e9 vy\u0161et\u0159en\u00ed.<\/div>\n<h3 class=\"wp-block-heading\">Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Ezedoc je dod\u00e1v\u00e1n certifikovan\u00fdm v\u00fdrobcem WHO-GMP s \u00faplnou dokumentac\u00ed COA. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b v prost\u00e9m, diskr\u00e9tn\u00edm balen\u00ed a ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00edm <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>. Your statement descriptor when paying by card shows the regulated payment processor (a regulated card-payment processor), never \u201cMedsBase\u201d or any medication name.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/bencid\/\">Bencid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tiova-rotacaps\/\">Tiova Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/serobid-rotacaps\/\">Serobid Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/headset\/\">Trinicalm Plus<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/xafinact\/\">Xafinact<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sni\u017euje hladinu cholesterolu<br \/>\n\u2705 Sni\u017euje riziko srde\u010dn\u00edch onemocn\u011bn\u00ed<br \/>\n\u2705 P\u0159edch\u00e1z\u00ed ateroskler\u00f3ze<br \/>\n\u2705 P\u0159edepisov\u00e1no l\u00e9ka\u0159i<br \/>\n\u2705 Mo\u017enost peror\u00e1ln\u00ed medikace<\/p>\n<p><strong>Lipikard<\/strong> obsahuje <strong>Ezetimib<\/strong>.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}